The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model

Anesthesia and Analgesia

Volumn 109, Issue 4, 2009, Pages 1297-1304

  Mecs, Laszlo ^a   Tuboly, Gabor ^b   Nagy, Endre ^c   Benedek, Gyorgy ^b   Horvath, Gyongyi ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; ENDOMORPHIN 1; KYNURENIC ACID; NALTREXONE; AMINO ACID RECEPTOR BLOCKING AGENT; LIGAND; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST; OLIGOPEPTIDE; OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; DRUG POTENTIATION; MALE; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN ASSESSMENT; PAIN RECEPTOR; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; ANIMAL; ANIMAL BEHAVIOR; ARTHRALGIA; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; EDEMA; HYPERALGESIA; INTRAARTICULAR DRUG ADMINISTRATION; METABOLISM; PATHOPHYSIOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION; TIME; WISTAR RAT;

ANALGESICS, OPIOID; ANIMALS; ARTHRALGIA; ARTHRITIS, EXPERIMENTAL; BEHAVIOR, ANIMAL; CARRAGEENAN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EDEMA; EXCITATORY AMINO ACID ANTAGONISTS; HYPERALGESIA; INJECTIONS, INTRA-ARTICULAR; INJECTIONS, SUBCUTANEOUS; KYNURENIC ACID; LIGANDS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; OLIGOPEPTIDES; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID; TIME FACTORS;

EID: 70349563885     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181b21c5e     Document Type: Article

References (64)

1. Fields HL, Emson PC, Leigh BK, Gilbert RFT, Iversen LL. Multiple opiate receptor sites on primary afferent fibers. Nature 1980;284:351-353
2. Stein C. Peripheral mechanisms of opioid analgesia. Anesth Analg 1993;76:182-191
3. Watterson G, Howard R, Goldman A. Peripheral opioids in inflammatory pain. Arch Dis Child 2004;89:679-681
4. Stein C, Millan MJ, Shippenberg TS, Peter K, Herz A. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J Pharmacol Exp Ther 1989;248:1269-1275 (Pubitemid 19100783)
5. Labuz D, Mousa SA, Schafer M, Stein C, Machelska H. Relative contribution of peripheral versus central opioid receptors to antinociception. Brain Res 2007;1160:30-38 (Pubitemid 47061436)
6. Stein C, Hassan AHS, Lehrberger K, Giefing J, Yassouridis A. Local analgesia effects of endogenous opioid peptides. Lancet 1993;342:321-324 (Pubitemid 23227559)
7. Kristensen JD, Post C, Gordh TJ, Svensson BA. Spinal cord morphology and antinociception after chronic intrathecal administration of excitatory amino acid antagonists in the rat. Pain 1993;54:309-316 (Pubitemid 23259290)
8. Zadina JE, Hackler L, Ge L-J, Kastin AJ. A potent and selective endogenous agonist for the mu-opiate receptor. Nature 1997; 386:499-502 (Pubitemid 27164076)
9. Ronai AZ, Szemenyei E, Kato E, Kocsis L, Orosz Gr, Al Khrasani M, Toth G. Endomorphin synthesis in rat brain from intracerebroventricularly injected [3H]-Tyr-Pro: a possible biosynthetic route for endomorphins. Regul Pept 2006;134:54-60
10. Horvath G. Endomorphin-1 and endomorphin-2. Pharmacology of the selective endogenous μ-opioid receptor agonists. Pharmacol Ther 2000;88:437-463
11. Obara I, Przewlocki R, Przewlocka B. Local peripheral effects of mu-opioid receptor agonists in neuropathic pain in rats. Neurosci Lett 2004;360:85-89 (Pubitemid 38471994)
12. Labuz D, Berger S, Mousa SA, Zollner C, Rittner HL, Shaqura MA, Segovia-Silvestre T, Przewlocka B, Stein C, Machelska H. Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain. J Neurosci 2006;26:4350-4358 (Pubitemid 44315394)
13. Straub RH, Wolff C, Fassold A, Hofbauer R, Chover-Gonzalez A, Richards LJ, Jessop DS. Antiinflammatory role of endomorphins in osteoarthritis, rheumatoid arthritis, and adjuvantinduced polyarthritis. Arthritis Rheum 2008;58:456-466 (Pubitemid 351294880)
14. Li ZM, Proud D, Zhang CF, Wiehler S, McDougall JJ. Chronic arthritis down-regulates peripheral mu-opioid receptor expression with concomitant loss of endomorphin 1 antinociception. Arthritis Rheum 2005;52:3210-3219 (Pubitemid 41447104)
15. McDougall JJ, Baker CL, Hermann PM. Attenuation of knee joint inflammation by peripherally administered endomorphin-1. J Mol Neurosci 2003;22:125-137
16. McDougall JJ, Barin AK, McDougall CM. Loss of vasomotor responsiveness to the mu-opioid receptor ligand endomorphin-1 in adjuvant monoarthritic rat knee joints. Am J Physiol 2004;286:R634-41
17. Barin AK, McDougall JJ. Endomorphin-1 causes synovial hypoaemia in rat knee joints via a capsaicin-sensitive neural pathway. Neurosci Lett 2003;344:21-24
18. Kinkelin I, Brocker EB, Koltzenburg M, Carlton SM. Localization of ionotropic glutamate receptors in peripheral axons of human skin. Neurosci Lett 2000;283:149-152 (Pubitemid 30156755)
19. Kolesnikov Y, Pasternak GW. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-d-aspartate antagonist. J Pharmacol Exp Ther 1999;290:247-252
20. Davidson EM, Carlton SM. Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors. Brain Res 1998;785:136-142
21. Lynch ME, Clark AJ, Sawynok J, Sullivan MJ. Topical amitriptyline and ketamine in neuropathic pain syndromes: an openlabel study. J Pain 2005;6:644-649 (Pubitemid 41395055)
22. Ayesh EE, Jensen TS, Svensson P. Effects of intra-articular ketamine on pain and somatosensory function in temporomandibular joint arthralgia patients. Pain 2008;137:286-294 (Pubitemid 351858605)
23. Ganong AH, Lanthorn TH, Cotman CW. Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord. Brain Res 1983;273:170-174
24. Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 2001;12:7463-7473 (Pubitemid 32904945)
25. Németh H, Toldi J, Vécsei L. Role of kynurenines in the central and peripherial nervous systems. Curr Neurovasc Res 2005;2:249-260 (Pubitemid 40980183)
26. Kekesi G, Joo G, Csullog E, Dobos I, Klimscha W, Toth K, Benedek G, Horvath G. The antinociceptive effect of intrathecal kynurenic acid and its interaction with endomorphin-1 in rats. Eur J Pharmacol 2002;445:93-96 (Pubitemid 34628437)
27. Parada-Turska J, Rzeski W, Zgrajka W, Majdan M, Kandefer- Szerszen M, Turski W. Kynurenic acid, an endogenous constituent of rheumatoid arthritis synovial fluid, inhibits proliferation of synoviocytes in vitro. Rheumatol Int 2006;26:422-426 (Pubitemid 43318322)
28. Horvath G, Kekesi G. Interaction of endogenous ligands mediating antinociception. Brain Res Rev 2006;52:69-92 (Pubitemid 44051533)
29. Horvath G, Kekesi G, Tuboly G, Benedek G. Antinociceptive interactions of triple and quadruple combinations of endogenous ligands at the spinal level. Brain Res 2007;1155:42-48 (Pubitemid 46891435)
30. Kolesnikov YA, Chereshnev I, Pasternak GW. Analgesic synergy between topical lidocaine and topical opioids. J Pharmacol Exp Ther 2000;295:546-551 (Pubitemid 30780985)
31. Kolesnikov Y, Soritsa D. Analgesic synergy between topical opioids and topical non-steroidal anti-inflammatory drugs in the mouse model of thermal pain. Eur J Pharmacol 2008;579:126-133
32. Peter-Szabo M, Kekesi G, Nagy E, Sziver E, Benedek G, Horvath G. Quantitative characterization of a repeated acute joint inflammation model in rats. Clin Exp Pharmacol Physiol 2007;34:520-526 (Pubitemid 46494481)
33. Wei H, Panula P, Pertovaara A. A differential modulation of allodynia, hyperalgesia and nociception by neuropeptide FF in the periaqueductal gray of neuropathic rats: interactions with morphine and naloxone. Neuroscience 1998;86:311-319 (Pubitemid 28270876)
34. Tallarida RJ, Porreca F, Cowan A. Statistical analysis of drugdrug and site-site interactions with isobolograms. Life Sci 1989;45:947-961 (Pubitemid 19251921)
35. Tallarida RJ, Stone DJ Jr, Raffa RB. Efficient designs for studying synergistic drug combinations. Life Sci 1997;61:PL417-25
36. Buerkle H, Pogatzki E, Pauser M, Bantel C, Brodner G, Mollhoff T, Van Aken H. Experimental arthritis in the rat does not alter the analgesic potency of intrathecal or intraarticular morphine. Anesth Analg 1999;89:403-408 (Pubitemid 29367725)
37. Barsun M, Jajcanin N, Vukelic B, Spoljaric J, Abramic M. Human dipeptidyl peptidase III acts as a post-proline-cleaving enzyme on endomorphins. Biol Chem 2007;388:343-348 (Pubitemid 46364475)
38. Shane R, Wilk S, Bodnar RJ. Modulation of endomorphin-2- induced analgesia by dipeptidyl peptidase IV. Brain Res 1999;815:278-286 (Pubitemid 29231321)
39. Bathon JM, Proud D, Mizutani S, Ward PE. Cultured human synovial fibroblasts rapidly metabolize kinins and neuropeptides. J Clin Invest 1992;90:981-991
40. Stein C, Gramsch C, Hassan AHS, Przewlocki R, Parsons CG, Peter K, Herz A. Local opioid receptors mediating antinociception in inflammation: endogenous ligands. Prog Clin Biol Res 1990;328:425-427
41. Coggeshall RE, Carlton SM. Ultrastructural analysis of NMDA, AMPA, and kainate receptors on unmyelinated and myelinated axons in the periphery. J Comp Neurol 1998;391:78-86
42. Lawand NB, McNeaney T, Westlund KN. Amino acid release into the knee joint: key role in nociception and inflammaton. Pain 2000;86:69-74
43. 2+/calmodulin-potein kinase II in nicotine-induced antinociception in mice. Eur J Pharmacol 2000;404:103-110
44. Damaj MI, Meyer EM, Martin BR. The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model. Neuropharmacology 2000;39:2785-2791 (Pubitemid 30753049)
45. Bernardini N, Sauer SK, Haberberger R, Fischer MJ, Reeh PW. Excitatory nicotinic and desensitizing muscarinic (M2) effects on C-nociceptors in isolated rat skin. J Neurosci 2001;21:3295-3302
46. Gilbert SD, Clark TM, Flores CM. Antihyperalgesic activity of epibatidine in the formalin model of facial pain. Pain 2001;89:159-165
47. Haberberger RV, Bernardini N, Kress M, Hartmann P, Lips KS, Kummer W. Nicotinic acetylcholine receptor subtypes in nociceptive dorsal root ganglion neurons of the adult rat. Auton Neurosci 2004;113:32-42 (Pubitemid 39024511)
48. Lang PM, Burgstahler R, Sippel W, Irnich D, Schlotter-Weigel B, Grafe P. Characterization of neuronal nicotinic acetylcholine receptors in the membrane of unmyelinated human C-fiber axons by in vitro studies. J Neurophysiol 2003;90:3295-3303 (Pubitemid 37430024)
49. Rashid H, Furue H, Yosihimura M, Ueda H. Tonic inhibitory role of alpha4beta2 subtype of nicotinic acetylcholine receptors on nociceptive transmission in the spinal cord in mice. Pain 2006;125:125-135 (Pubitemid 44498970)
50. Wang Y, Su DM, Wang RH, Liu Y, Wang H. Antinociceptive effects of choline against acute and inflammatory pain. Neuroscience 2005;132:49-56 (Pubitemid 40380713)
51. Wang JH, Simonavicius N, Wu XS, Swaminath G, Reagan J, Tian H, Ling L. Kynurenic acid as a ligand for orphan G proteincoupled receptor GPR35. J Biol Chem 2006;281:22021-22028 (Pubitemid 44181906)
52. Ohshiro H, Tonai-Kachi H, Ichikawa K. GPR35 is a functional receptor in rat dorsal root ganglion neurons. Biochem Biophys Res Commun 2008;365:344-348 (Pubitemid 350137295)
53. Trujillo KA, Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 1991;251:85-87 (Pubitemid 21916858)
54. Dickenson AH. NMDA receptor antagonists: interactions with opioids. Acta Anaesthesiol Scand 1997;41:112-115
55. Nishizawa M, Yaksh TL, Weber E. Effects of intrathecal NMDA and non-NMDA antagonists on acute thermal nociception and their interaction with morphine. Anesthesiology 1998;89:715-722 (Pubitemid 28423971)
56. Wiesenfeld-Hallin Z. Combined opioid-NMDA antagonist therapies. Drugs 1999;55:1-4
57. Joo G, Horvath G, Klimscha W, Kekesi G, Dobos I, Szikszay M, Benedek G. The effects of ketamine and its enantiomers on the morphine- or dexmedetomidine-induced antinociception after intrathecal administration in rats. Anesthesiology 2000;93:231-241 (Pubitemid 30436698)
58. Yamamoto T, Shimoyama N, Mizuguchi T. The effects of morphine, MK-801, an NMDA antagonist, and CP-96,345, an NK-1 antagonist, on the hyperesthesia evoked by carageenan injection in the rat paw. Anesthesiology 1993;78:124-133
59. Hao SL, Takahata O, Iwasaki H. Isobolographic analysis of interaction between spinal endomorphin-1, a newly isolated endogenous opioid peptide, and lidocaine in the rat formalin test. Neurosci Lett 1999;276:177-180 (Pubitemid 29535360)
60. Wang Y-Q, Zhu C-B, Wu G-C, Cao X-D, Wang Y, Cui DF. Effects of orphanin FQ on endomorphin-1 induced analgesia. Brain Res 1999;835:241-246 (Pubitemid 29343786)
61. Hao S, Takahata O, Iwasaki H. Intrathecal endomorphin-1 produces antinociceptive activities modulated by alpha 2-adrenoceptors in the rat tail flick, tail pressure and formalin tests. Life Sci 2000;66:PL195-PL200 (Pubitemid 30152317)
62. Csullog E, Joo G, Toth G, Dobos I, Benedek G, Horvath G. Antinociceptive effect of continuous intrathecal administration of endomorphin-1. Pain 2001;94:31-38 (Pubitemid 32907555)
63. Horvath G, Joo G, Dobos I, Klimscha W, Toth G, Benedek G. The synergistic antinociceptive interactions of endomorphin-1 with dexmedetomidine and/or S(+)-ketamine in rats. Anesth Analg 2001;93:1018-1024 (Pubitemid 32905997)
64. Khalil Z, Sanderson K, Modig M, Nyberg F. Modulation of peripheral inflammation by locally administered endomorphin-1. Inflamm Res 1999;48:550-556 (Pubitemid 29495638)